Identification of Prognostic Biomarkers of Cutaneous Melanoma Based on Analysis of Tumor Mutation Burden

BACKGROUND: Immunotherapy offers a novel approach for the treatment of cutaneous melanoma, but the clinical efficiency varies for individual patients. In consideration of the high cost and adverse effects of immunotherapy, it is essential to explore the predictive biomarkers of outcomes. Recently, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Jiaqiong, Lin, Yan, Huang, Zena, Li, Xiaoyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683164/
https://www.ncbi.nlm.nih.gov/pubmed/33273963
http://dx.doi.org/10.1155/2020/8836493

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683164/
https://www.ncbi.nlm.nih.gov/pubmed/33273963
http://dx.doi.org/10.1155/2020/8836493

Ejemplares similares